MattEKalaycioMD

PubMed

• 9 citations
  Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.
  Brian T. Hill, Lisa Rybicki, Theresa A. Urban, Mariana Lucena, Deepa Jagadeesh
  Biology of Blood and Marrow Transplantation. 2020-02-01
• 707 citations
  Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation
  Philippe Armand, Haesook T. Kim, Brent R. Logan, Zhiwei Wang, Edwin P. Alyea
  Blood. 2014-06-05
• 28 citations
  Allogeneic Hematopoietic Cell Transplant for Prolymphocytic Leukemia
  Matt Kalaycio, Manisha Kukreja, Ann E. Woolfrey, Jeff Szer, Jorge E. Cortes
  Biology of Blood and Marrow Transplantation. 2010-04-01

Journal Articles

• Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell Transplantation  
  Deepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature
• Neutropenic Fever During Peripheral Blood Progenitor Cell Mobilization Is Associated with Decreased CD34+ Cell Collection and Increased Apheresis Collection Days  
  Mat Kalaycio, Robert Dean, Jack Khouri, Brad Pohlman, Aleksandr Lazaryan, Edward Copelan, Steven Andresen, Ronald Sobecks, Hien Liu, Journal of Clinical Apheresis

Abstracts/Posters

• Long-Term Experience with Large Granular Lymphocytic Leukemia Evolving after Solid Organ and Hematopoietic Stem Cell Transplantation
  Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...
  Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia
  Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Identifying Factors That Predict for Unplanned Readmissions for Acute Myeloid Leukemia Patients Receiving Consolidation Cytarabine Based Therapies
  Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Targeted Treatment and Survival Following Relapse after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia and MDS in the Contemporary Era
  Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Pattern of Somatic Mutation Changes from Diagnosis to Relapse Following Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Acute Myeloid Leukemia (AML) and My...
  Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Outcomes and Factors Impacting Use of Axicabtagene Ciloleucel in Refractory and Relapsed Large B-Cell Lymphoma: An Intent-to-Treat Analysis
  Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• A Single Arm, Phase II Study of Eltrombopag to Enhance Platelet Count Recovery in Older Patients with Acute Myeloid Leukemia (AML) Undergoing Remission Induction Therapy
  Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Survival Outcomes of Patients with Therapy-Related Acute Myeloid Leukemia in the United States 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• TP53 Mutations in Myeloid Neoplasm Patients with and without Significant Personal and Family History of CancerClinically Relevant Abstract 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Impact of Clinical Versus Biochemical Progression on Post-Progression Survival in Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Riding the Wave: Clinical Management of Myeloid Malignancies in an Era of Novel Therapies 
  60th American Society of Hematology Annual Meeting - 11/30/2018
• Join now to see all